Home > News > Recent cases

Crushcov v Hyland, Richardson & Sky [2025] EWHC 1117 (Ch)13 May 2025Judgment in Crushcov v Hyland, Richardson & Sky [2025] EWHC 1117 (Ch) was handed down by HHJ Paul Matthews on 13th May.  Jonathan Hill acted for Sky on its successful application for summary judgment, dismissing this claim alleging plagiarisation of the television series Britannia.
Optis Cellular v Apple Retail [2025] EWCA Civ 5521 May 2025Judgment in Optis Cellular v Apple Retail [2025] EWCA Civ 552 was handed down by Lord Justice Newey, Lord Justice Arnold and Lord Justice Birss on 1st May.  Adrian Speck KC, James Abrahams KC, Isabel Jamal and Thomas Jones appeared for the appellants.  
Mediatek v Huawei [2025] EWHC 1016 (Pat)29 April 2025Mr Justice Meade handed down judgment ex tempore in Mediatek v Huawei on the 15th April. The judgment concerns expedition and a 15+ day FRAND trial was expedited to February 2026 in light of the injunction risk in Germany, the UPC and Brazil. An approved judgment was supplied on the 28th April. Andrew Lykiardopoulos KC […]
Generics (UK) Ltd, Teva and Glenmark v AstraZeneca Re: Dapagliflozin [2025] EWHC 1012 (Pat)28 April 2025Judgment in Generics (UK) Ltd, Teva and Glenmark v AstraZeneca Re: Dapagliflozin [2025] EWHC 1012 (Pat) was handed down by Michael Tappin KC (sitting as a Deputy Judge of the High Court) on 28th April 2025.  Lindsay Lane KC acted for the Defendant.
AstraZeneca v Glenmark [2025] EWCA Civ 48016 April 2025James Abrahams KC represented Glenmark in proceedings brought by AstraZeneca to restrain its launch of a generic dapagliflozin, a medicine for treatment of type 2 diabetes and other conditions. Glenmark had already brought a claim for revocation of AstraZeneca’s patent and SPC protecting dapagliflozin, which was tried in March 2025, with judgment reserved. Glenmark gave […]